Centrosome amplification in adult T-cell leukemia and human T-cell leukemia virus type 1 Tax-induced human T cells

Cancer Science

Volumn 97, Issue 9, 2006, Pages 836-841

  Nitta, Takayuki ^a   Kanai, Masayuki ^b   Sugihara, Eiji ^a,c   Tanaka, Masakazu ^d   Sun, Binilian ^a   Nagasawa, Toshiro ^a   Sonoda, Shunro ^e   Saya, Hideyuki ^c   Miwa, Masanao ^a,d  

^a UNIVERSITY OF TSUKUBA   (Japan)

^b UNIVERSITY OF CINCINNATI COLLEGE OF MEDICINE   (United States)

^c KUMAMOTO UNIVERSITY   (Japan)

^d NAGAHAMA INSTITUTE OF BIO SCIENCE AND TECHNOLOGY   (Japan)

^e KAGOSHIMA UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

2 BIS(2 HYDROXYETHYL)AMINO 9 ISOPROPYL 6 (4 METHOXYBENZYLAMINO)PURINE; CYCLIN DEPENDENT KINASE; CYCLIN DEPENDENT KINASE INHIBITOR; INDIRUBIN; TAX PROTEIN;

ARTICLE; CELL ISOLATION; CELL LINE; CENTROSOME; CHROMOSOMAL INSTABILITY; CONTROLLED STUDY; DEREGULATION; ENZYME ACTIVITY; GENE AMPLIFICATION; HUMAN; HUMAN CELL; HUMAN T CELL LEUKEMIA VIRUS; LEUKEMOGENESIS; MICRONUCLEUS; NONHUMAN; PRIORITY JOURNAL; PROTEIN FUNCTION; PROTEIN INDUCTION; T CELL LEUKEMIA; T LYMPHOCYTE; VIRUS CELL TRANSFORMATION;

CELL TRANSFORMATION, VIRAL; CENTROSOME; FLUORESCENT ANTIBODY TECHNIQUE; GENE PRODUCTS, TAX; HUMANS; IMMUNOBLOTTING; JURKAT CELLS; LEUKEMIA-LYMPHOMA, T-CELL, ACUTE, HTLV-I-ASSOCIATED; T-LYMPHOCYTES;

EID: 33746618284     PISSN: 13479032     EISSN: 13497006     Source Type: Journal    
DOI: 10.1111/j.1349-7006.2006.00254.x     Document Type: Article

References (38)

1. Fukasawa K. Centrosome amplification, chromosome instability and cancer development. Cancer Lett 2005; 230: 6-19.
2. Meraldi P, Nigg EA. The centrosome cycle. FEBS Lett 2002; 521: 9-13.
3. Lengauer C, Kinzler KW, Vogelstein B. Genetic instabilities in human cancers. Nature 1998; 396: 643-9.
4. Carroll PE, Okuda M, Horn HF et al. Centrosome hyperamplification in human cancer: Chromosome instability induced by p53 mutation and/or Mdm2 overexpression. Oncogene 1999; 18: 1935-44.
5. Duensing S, Lee LY, Duensing A et al. The human papillomavirus type 16, E6 and E7 oncoproteins cooperate to induce mitotic defects and genomic instability by uncoupling centrosome duplication from the cell division cycle. Proc Natl Acad Sci USA 2000; 97: 10002-7.
6. Fukasawa K, Choi T, Kuriyama R, Rulong S, Vande Woude GF. Abnormal centrosome amplification in the absence of p53. Science 1996; 271: 1744-7.
7. Xu X, Weaver Z, Linke SP et al. Centrosome amplification and a defective G2-M cell cycle checkpoint induce genetic instability in BRCA1 exon 11 isoform-deficient cells. Mol Cell 1999; 3: 389-95.
8. Mantel C, Braun SE, Reid S et al. p21 (cip-1 / waf-1) deficiency causes deformed nuclear architecture, centriole overduplication, polyploidy, and relaxed microtubule damage checkpoints in human hematopoietic cells. Blood 1999; 93: 1390-8.
9. Krämer A, Neben K, Ho AD. Centrosome aberrations in hematological malignancies. Cell Biol Int 2005; 29: 375-83.
10. Uchiyama T, Yodoi J, Sagawa K, Takatsuki K, Uchino H. Adult T-cell leukemia: Clinical and hematologic features of 16 cases. Blood 1977; 50: 481-92.
11. Kamada N, Sakurai M, Miyamoto K et al. Chromosome abnormalities in adult T-cell leukemia/lymphoma: A karyotype review committee report. Cancer Res 1992; 52: 1481-93.
12. Matsuoka M. Human T-cell leukemia virus type I (HTLV-I) infection and the onset of adult T-cell leukemia (ATL). Retrovirology 2005; 2: 27.
13. Okamoto T, Ohno Y, Tsugane S et al. Multi-step carcinogenesis model for adult T-cell leukemia. Jpn J Cancer Res 1989; 80: 191-5.
14. Tanaka A, Takahashi C, Yamaoka S, Nosaka T, Maki M, Hatanaka M. Oncogenic transformation by the tax gene of human T-cell leukemia virus type I in vitro. Proc Natl Acad Sci USA 1990; 87: 1071-5.
15. Grassmann R, Dengler C, Muller-Fleckenstein I et al. Transformation to continuous growth of primary human T lymphocytes by human T-cell leukemia virus type I, X-region genes transduced by a Herpesvirus saimiri vector. Proc Natl Acad Sci USA 1989; 86: 3351-5.
16. Grossman WJ, Kimata JT, Wong FH, Zutter M, Ley TJ, Ratner L. Development of leukemia in mice transgenic for the tax gene of human T-cell leukemia virus type I. Proc Natl Acad Sci USA 1995; 92: 1057-61.
17. Majone F, Semmes OJ, Jeang KT. Induction of micronuclei by HTLV-I Tax: A cellular assay for function. Virology 1993; 193: 456-9.
18. Yoshida M. Multiple viral strategies of HTLV-1 for dysregulation of cell growth control. Annu Rev Immunol 2001; 19: 475-96.
19. Marriott SJ, Semmes OJ. Impact of HTLV-I Tax on cell cycle progression and the cellular DNA damage repair response. Oncogene 2005; 24: 5986-95.
20. Shimoyama M. Diagnostic criteria and classification of clinical subtypes of adult T-cell leukaemia-lymphoma. A report from the Lymphoma Study Group (1984-87). Br J Haematol 1991; 79: 428-37.
21. Suga T, Kameyama T, Kinoshita T et al. Infection of rats with HTLV-1: A small-animal model for HTLV-1 carriers. Int J Cancer 1991; 49: 764-9.
22. Nagata K, Ohtani K, Nakamura M, Sugamura K. Activation of endogenous c-fos proto-oncogene expression by human T-cell leukemia virus type I-encoded p40tax protein in the human T-cell line, Jurkat. J Virol 1989; 63: 3220-6.
23. Hoessel R, Leclerc S, Endicott JA et al. Indirubin, the active constituent of a Chinese antileukaemia medicine, inhibits cyclin-dependent kinases. Nat Cell Biol 1999; 1: 60-7.
24. Brooks EE, Gray NS, Joly A et al. CVT-313, a specific and potent inhibitor of CDK2 that prevents neointimal proliferation. J Biol Chem 1997; 272: 29207-11.
25. Bangham CR. The immune control and cell-to-cell spread of human T-lymphotropic virus type 1. J General Virol 2003; 84: 3177-89.
26. Müller WU, Nüsse M, Miller BM, Slavotinek A, Viaggi S, Streffer C. Micronuclei: A biological indicator of radiation damage. Mutat Res 1966; 366: 163-9.
27. Matsumoto Y, Hayashi K, Nishida E. Cyclin-dependent kinase 2 (Cdk2) is required for centrosome duplication in mammalian cells. Curr Biol 1999; 9: 429-32.
28. Duensing S, Duensing A, Lee DC et al. Cyclin-dependent kinase inhibitor indirubin-3′-oxime selectively inhibits human papillomavirus type 16, E7-induced numerical centrosome anomalies. Oncogene 2004; 23: 8206-15.
29. D'Assoro AB, Lingle WL, Salisbury JL. Centrosome amplification and the development of cancer. Oncogene 2002; 21: 6146-53.
30. Matsumura M, Kushida S, Ami Y et al. Quantitation of HTLV-I provirus among seropositive blood donors: Relation with antibody profile using synthetic peptides. Int J Cancer 1993; 55: 220-2.
31. Haase SB, Winey M, Reed SI. Multi-step control of spindle pole body duplication by cyclin-dependent kinase. Nat Cell Biol 2001; 3: 38-42.
32. Meraldi BP, Lhukas J, Fry AM, Bartek J, Nigg EA. Centrosome duplication in mammalian somatic cells requires E2F and Cdk2-cyclin A. Nat Cell Biol 1999; 1: 88-93.
33. Iwanaga R, Ohtani K, Hayashi T, Nakamura M. Molecular mechanism of cell cycle progression induced by the oncogene product Tax of human T-cell leukemia virus type I. Oncogene 2001; 20: 2055-67.
34. Kehn K, De La Fuente C, Strouss K et al. The HTLV-I Tax oncoprotein targets the retinoblastoma protein for proteasomal degradation. Oncogene 2005; 20: 525-40.
35. Li J, Li H, Tsai MD. Direct binding of the N-terminus of HTLV-1 tax oncoprotein to cyclin-dependent kinase 4 is a dominant path to stimulate the kinase activity. Biochemistry 2003; 42: 6921-8.
36. Kehn K, Deng L, De La Fuente C et al. The role of cyclin D2 and p21/waf1 in human T-cell leukemia virus type 1 infected cells. Retrovirology 2004; 1: 6.
37. Peloponese Jr JM, Haller K, Miyazato A, Jeang KT. Abnormal centrosome amplification in cells through the targeting of Ran-binding protein-1 by the human T cell leukemia virus type-1 Tax protein. Proc Natl Acad Sci USA 2005; 102: 18974-9.
38. Duensing A, Liu Y, Tseng M, Malumbres M, Barbacid M, Duensing S. Cyclin-dependent kinase 2 is dispensable for normal centrosome duplication but required for oncogene-induced centrosome overduplication. Oncogene 2006; 25: 2943-9.